Cipla (NSE:CIPLA) Cyclically Adjusted PB Ratio: (As of Jul. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CIPLA Cipla Ltd NSE:CIPLA
97 GF Score
Price ₹1,410.60
GF Value ₹1,551.45
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cipla Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cipla  (NSE:CIPLA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cipla Cyclically Adjusted PB Ratio Related Terms


Cipla Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Cipla's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla Cyclically Adjusted PB Ratio Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.82 3.90 5.93 5.25 4.01

Cipla Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.14 0.00 4.01 0.00

NSE:CIPLA vs ZTS, UTHR: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cipla Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cipla's Cyclically Adjusted PB Ratio falls into.


NSE:CIPLA
97GF Score
Cipla Ltd NSE:CIPLA
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipla Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cipla's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Cipla's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/166.1454*166.1454
=0.000

Current CPI (Jun. 2026) = 166.1454.

Cipla Quarterly Data

Book Value per Share CPI Adj_Book
201609 153.071 105.961 240.013
201612 0.000 105.196 0.000
201703 155.917 105.196 246.254
201706 0.000 107.109 0.000
201709 165.200 109.021 251.760
201712 0.000 109.404 0.000
201803 176.734 109.786 267.461
201806 0.000 111.317 0.000
201809 183.072 115.142 264.166
201812 0.000 115.142 0.000
201903 186.326 118.202 261.901
201906 0.000 120.880 0.000
201909 193.484 123.175 260.982
201912 0.000 126.235 0.000
202003 195.514 124.705 260.485
202006 0.000 127.000 0.000
202009 211.777 130.118 270.415
202012 0.000 130.889 0.000
202103 227.246 131.771 286.528
202106 0.000 134.084 0.000
202109 240.899 135.847 294.627
202112 0.000 138.161 0.000
202203 258.321 138.822 309.165
202206 0.000 142.347 0.000
202209 271.180 144.661 311.454
202212 0.000 145.763 0.000
202303 290.005 146.865 328.078
202306 0.000 150.280 0.000
202309 307.502 151.492 337.246
202312 0.000 152.924 0.000
202403 330.784 153.035 359.123
202406 0.000 155.789 0.000
202409 351.204 157.882 369.585
202412 0.000 158.323 0.000
202503 386.241 157.552 407.309
202506 0.000 159.755 0.000
202509 407.531 162.289 417.214
202512 0.000 163.281 0.000
202603 426.252 164.272 431.112
202606 0.000 166.145 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cipla (NSE:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of ₹1,410.60 is trading 9.1% below its estimated GF Value™ of ₹1,551.45. GuruFocus considers Cipla to be Fairly Valued.

Key valuation signals for NSE:CIPLA:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹1,551.45 vs. price of ₹1,410.60 (9.1% below fair value)
  • GF Score™: 97/100 with 3 warning signs

No single metric tells the full story. See the NSE:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cipla Business Description

Other Exchanges 500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
97GF Score

Get the complete analysis for NSE:CIPLA

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,410.60
Price
₹1,551.45
GF Value